Recent Health Care Deals, week ending 10.14.2016

TargetAcquirerPrice Takeda Pharmaceutical Co. License to Humabody-based therapeutics$36 million Lutheran Social Ministries of New JerseySt. Anne Villa$16 million Regeneron Pharmaceuticals, Inc. License to aflibercept$10 million Aris RadiologyUS TeleradiologyN/A American Renal Associates, LLC2 dialysis centers in... Read More »

Recent Health Care Deals, week ending 10.07.2016

AcquirerTargetPrice ICU Medical Inc. Pfizer's global infusion therapy business$1 billion Allergan plcWorldwide rights to MEDI2070$250 million Wolters Kluwer, NVEmmi Solutions$170 million WellCare Health Plans Inc. Care1st Health Plan Arizona Inc. $157.5 million Accord Healthcare LimitedActavis Generics assets$760.4... Read More »

Preliminary Data: Q3 M and A

There’s still one week left to go in the month of September, and the third quarter, but the trends have already established themselves. Merger and acquisition activity in health care dropped 20% compared with the previous quarter, down to 331 deals compared with 415 in Q2:16. The third quarter also pales in comparison to the same quarter a year earlier, when 411 deals were posted (-19%). Even with a week to go, it’s obvious that deal making has slowed considerably and likely won’t recover to those levels. Spending was also much lower than in the previous quarter, and the year-ago period. At the moment, $45.9 billion is on the books for Q3:16, down 48% compared with... Read More »